Association of physicians sex with risk factor control in treated hypertensive patients from Swedish primary healthcare

Journal of Hypertension

Volumn 26, Issue 10, 2008, Pages 2050-2056

  Journath, Gunilla ^a,b   Hellénius, Mai Lis ^a   Manhem, Karin ^c   Kjellgren, Karin I ^d   Nilsson, Peter M ^e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Merck Sharp Dohme (Sweden)   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e LUND UNIVERSITY   (Sweden)

Author keywords

blood pressure; hypertension; lipids; physician; primary health; sex

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT; HYPOCHOLESTEROLEMIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOCTOR PATIENT RELATION; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; AGED; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; FEMALE PHYSICIAN; GENERAL PRACTITIONER; HYPERCHOLESTEROLEMIA; MIDDLE AGED; SWEDEN; TREATMENT OUTCOME;

AGED; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PHYSICIANS, WOMEN; SEX FACTORS; SWEDEN; TREATMENT OUTCOME;

EID: 58149122946     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32830a4a3b     Document Type: Article

References (32)

1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275:1571-1576.
2. The Swedish Council on Technology Assessment in Healthcare.Moderately elevated blood pressure. Report Volumes 1-3. Stockholm, Sweden: Swedish Council on Technology Assessment in Healthcare; 2004.
3. Staessen JA, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens 1998; 12:587-592.
4. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2007; 25:1105-1187.
5. World Health Organization, International Society of Hypertension Writing Group. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983-1992.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
7. Persson M, Carlberg B, Mjorndal T, Asplund K, Bohlin J, Lindholm L. 1999 WHO/ISH Guidelines applied to a 1999 MONICA sample from northern Sweden. J Hypertens 2002; 20:29-35.
8. Weinehall L, Öhgren B, Persson M, Stegmayr B, Boman K, Hallmans G, et al. High remaining risk in poorly treated hypertension, the 'rule of halves'still exists. J Hypertens 2002; 20:2081-2088.
9. Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the Health Survey for England. J Hypertens 2006; 24:1187-1192.
10. Westheim A, Klemetsrud T, Tretli S, Stoikke HP, Oisen H. Blood pressure evels in treated hypertensive patients in general practice in Norway. Blood Press 2001; 10:37-42.
11. Joffres MR, Hamet P, MacLean DR, Ultalien GJ, Fodor G. Distribution ofblood pressure and hypertension in Canada and the United States. Am J Hypertens 2001; 14:1099-1105.
12. Roumie CL, Elasy TA, Greevy R, Grif?n MR, Liu X, Stone WJ, et al. Improving blood pressure control through provider education, provider alerts, and patient education. Ann Intern Med 2006; 145: 165-175.
13. Journath G, Hellenius M-L, Petersson U, Theobald H, Nilsson PM. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden. Eur J Cardiovasc Prev Rehabil 2008; 15:258-262.
14. Wayne WD. Biostatistics: a foundation for analysis in the health sciences, 6th ed. New York, NY: John Wiley & Sons; 1995.
15. Montgomery DC. Design and analysis of experiments, 3rd ed. New York, NY: John Wiley & Sons; 1991.
16. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-speci?c relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
17. Luepker RW, Arnett DK, Jacobs DR, Duval SJ, Folsom AR, Armstrong C, et al. Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart Survey. Am J Med 2006; 119:42-49.
18. Li C, Engström G, Hedblad B, Berglund G, Janzon L. Blood pressure control and risk of stroke. Stroke 2005; 36:725-730.
19. Bertakis KD, Franks P, Azari R. Effects of physician gender on patient satisfaction. JAMA 2003; 58:68-75.
20. Comstock LM, Hooper EM, Goodwin JM, Goodwin JS. Physician behaviors that correlate with patient satisfaction. J Med Educ 1982; 57:105-112.
21. Roter DL, Celler G, Bernhardt BA, Larson SM, Doksum T. Effects of obstetrician gender on communication and patient satisfaction. Obstet Gynecol 1999; 93:634-641.
22. Schmittdiel J, Grumbach K, Selby JV, Quesenberry CP. Effect of physician and patient gender concordance on patient satisfaction and preventive care practices. Gen Intern Med 2000; 15:761-769.
23. Meeuwesen L, Schaap C, Van der Staak C. Verbal analysis of doctor-patient communication. Soc Sci Med 1991; 32:1143-1150.
24. Roter D, Lipkin M Jr, Korsgaard A. Sex differences in patients' and physicians' communication during primary care medical visits. Med Care 1991; 29:1083-1093.
25. Rhoades DR, McFarland KF, Finch WH, Johnson AO. Speaking and interruptions during primary care of?ce visits. Fam Med 2001; 33:528-532.
26. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2005: CD000011. doi: 10.1002/14651858.CD000011.pub2.
27. Millar JA, Accioloy JM. Measurement of blood pressure may be affected by an interaction between subject and observer based on gender. J Hum Hypertens 1996; 10:449-453.
28. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caul?eld M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentration in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361:1149-1158.
29. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995; 332:1758-1766.
30. Wingard DL, Barett-Connor E. Heart disease and diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, ReiberGE, Benett PH, editors. Diabetes in America., 2nd ed. Bethesda, MD: National Institutes of Health; 1995.pp. 429-448.
31. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28:88-136.
32. Svensson S, Linell P, Kjellgren KI.Making sense of blood pressure values in follow-up appointments for hypertension. Int J Cardiol 2008; 123:108-116.